• Home
  • NEW DAY MEDICINE
  • 1 (51) 2023
  • 48 -1 (51) 2023 — Satvaldieva E.A., Khodjiev B.F. — CARDIOPLEGIC MYOCARDIAL PROTECTION IN PEDIATRIC CARDIAC SURGERY: CURRENT STATUS

48 -1 (51) 2023 — Satvaldieva E.A., Khodjiev B.F. — CARDIOPLEGIC MYOCARDIAL PROTECTION IN PEDIATRIC CARDIAC SURGERY: CURRENT STATUS

CARDIOPLEGIC MYOCARDIAL PROTECTION IN PEDIATRIC CARDIAC SURGERY: CURRENT STATUS

Satvaldieva E.A., National Children’s Medical Center Tashkent pediatric medical institute. Tashkent, Uzbekistan.

Khodjiev B.F., National Children’s Medical Center

Alimov A.B., National Children’s Medical Center

Kuralov E.T. National Children’s Medical Center

Resume

This article provides a brief overview of the current problem of modern pediatric cardioanesthesiology – intraoperative cardioplegic protection of the myocardium during open heart surgery. The combination of hypothermia and potassium cardioplegic arrest has become the most common method of myocardial protection in the evolution of myocardioprotection. The review touched upon the classification and types of cardioplegic solutions, their advantages and disadvantages based on meta-analyses. The current state of the problem is highlighted.

Key words: myocardium, cardioprotection, pediatric cardiac surgery, early age, intraoperative protection, cardiopulmonary bypass.

First page

280

Last page

285

For citation: Satvaldieva E.A., Khodjiev B.F., Alimov A.B., Kuralov E.T. – CARDIOPLEGIC MYOCARDIAL PROTECTION IN PEDIATRIC CARDIAC SURGERY: CURRENT STATUS //New Day in Medicine 1(51)2023 280-285 https://clck.ru/33S9bk

LIST OF REFERENCES:

  1. Melrose D.G., Dreyer B., Bentall H.H., Baker Jb.E. Elective cardiac arrest. //Lancet1955; 269:21-2. DOI: 10.1016/s0140-6736(55)93381-x
  2. Chambers D.J., Fallouh H.B. Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. //Pharmacol Ther2010;127:41– 52. DOI: 10.1016/j.pharmthera.2010.04.001
  3. Bretschneider H.J. Survival time and recuperative time of the heart in normothermia and hypothermia. //Verh Dtsch Ges Krei- slaufforsch1964; 30:11–34. https://pubmed.ncbi.nlm.nih.gov/14271639/
  4. Swan H. Clinical hypothermia: a lady with a past and some promise for the future. Surgery 1973; 73:736–58. DOI: 10.1097/00000658-195313830-00009
  5. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the international society for heart and lung transplantation: eighteenth official report—2001. //J Heart Lung Transplant2001;20:805–15. DOI: 10.1016/s1053-2498(00)00138-8
  6. Manrique A.M., Kelly K., Litchenstein S.E. The effects of cardiopulmonary bypass following pediatric cardiac surgery. In: Muñoz R, Morell VO, da Cruz EM, Vetterly CG, eds. //Critical Care of Children with Heart Disease. Basic Medical and Surgical Concepts. London: Springer-Verlag, 2010;103–20.  https://link.springer.com/book/10.1007/978-3-030-21870-6
  7. Goodwin G.W., Ahmad F., Doenst T., Taegtmeyer H. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. //Am J Physiol1998; 274:H1239–47. DOI: 10.1152/ajpheart.1998.274.4.H1239
  8. Lopaschuk G.D., Spafford M.A., Marsh D.R. Glycolysis is pre- dominant source of myocardial ATP production immediately after birth. //Am J Physiol1991; 261:H1698–705. DOI: 10.1152/ajpheart.1991.261.6.H1698
  9. Julia P.L., Kofsky E.R., Buckberg G.D., Young H.H., Bugyi H.I. Studies of myocardial protection in the immature heart. I. Enhanced tolerance of immature versus adult myocardium to global ischemia with reference to metabolic differences. //J Thorac Cardiovasc Surg1990;100:879–87. https://pubmed.ncbi.nlm.nih.gov/2246910/
  10. Imura H., Caputo M., Parry A., Pawade A., Angelini G.D., Sule- iman M.S. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. //Circulation2001;103:1551–6.  DOI: 10.1161/01.cir.103.11.1551
  11. Gombosova I., Boknik P., Kirchhefer U. et al. Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphates. //Am J Physiol1998;274:H2123–32. doi: 10.1155/2019/2675972
  12. Перхов В.И. Послеоперационная летальность в федеральных кардиохирургических клиниках: гамбургский счет //Менеджер здравоохранения. 2017. No9. С.6-15. https://cyberleninka.ru/article/n/posleoperatsionnaya-letalnost-v-federalnyh-kardiohirurgicheskih-klinikah-gamburgskiy-schet/viewer
  13. Teoh K.H., Mickle D.A., Weisel R.D. et al. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. //J Thorac Cardiovasc Surg1992;104:159–64. https://pubmed.ncbi.nlm.nih.gov/1614202/del
  14. Nido P.J., Mickle D.A., Wilson G.J. et al. Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot. //Circulation1987;76:V174–9. https://europepmc.org/article/med/2959398
  15. Клышко Н.К. Щава С.П., Фургал А.А., Раповка В.Г., Шуматов В.Б., Силаев А.А., Зенина А.А., Филиппова Е.А., Гончарук Р.А., Сорокин В.А. Кардиоплегия и защита миокарда в кардиохирургии: современные тенденции //Кардиология и сердечно-сосудистая хирургия. 2020. Т. 13, No2. С. 108-113; DOI: 10.17116/kardio202013021108
  16. Баяндин Н.Л. Кристаллоидная гипотермическая и кровяная нормотермическая кардиоплегия //Журнал имени академика Б.В. Петровского «Клиническая и экспериментальная хирургия», 2020. Т. 8[1]. No1. С. 80-89;
  17. Хубулава Г.Г., Наумов А.Б., Марченко С.П., Терешенко О.Ю., Кулемин Е.С., Романовский Д.Ю., Бирюков А.В. Модифицированная методика комбинированной кристаллоидно-кровяной холодовой кардиоплегии с уменьшенным объемом заполнения системы доставки для хирургической коррекции врожденных пороков сердца у детей //Детские болезни сердца и сосудов. 2019. No16 [1]. С. 5-15. DOI: 10.24022/1810-0686-2019-16-1-5-15. DOI: https://doi.org/10.24022/1810-0686-2019-16-1-5-15
  18. Doenst T., Schlensak C., Beyersdorf F. Cardioplegia in pediatric cardiac surgery: do we believe in magic? //Ann Thorac Surg 2003;75:1668–77. DOI: 10.1016/s0003-4975(02)04829-4
  19. Liu J., Feng Z., Zhao J., Li B., Long C. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. //ASAIO J2008;54:470– 3. DOI: 10.1097/MAT.0b013e318188b86c
  20. Reichenspurner H., Russ C., Uberfuhr P. et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. //Eur J Cardiothoracic Surg1993;7:414–9. DOI: 10.1016/1010-7940(93)90005-v

file

download